20/11/2007 - 12:10

Resonance Health extends distribution deal with Novartis

20/11/2007 - 12:10

Bookmark

Save articles for future reference.

Claremont-based magnetic resonance imaging technology developer Resonance Health Ltd has extended the distribution deal for its liver iron monitoring device FerriScan with Switzerland-based Novartis AG, the company has announced.

To read our articles you will need to either login or subscribe.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options